J Zapf

741 total citations
16 papers, 605 citations indexed

About

J Zapf is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cancer Research. According to data from OpenAlex, J Zapf has authored 16 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in J Zapf's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). J Zapf is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). J Zapf collaborates with scholars based in Switzerland, United Kingdom and Sweden. J Zapf's co-authors include J.C. Irminger, Walter Ziegler, Gisela K. Haselbacher, R Humbel, D.L. Andress, Michael Kiefer, Pico Caroni, Corinna Schneider, E. R. Froesch and Armin Kurtz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

J Zapf

16 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J Zapf Switzerland	10	311	299	130	94	68	16	605
Mary Boes United States	14	438 1.4×	538 1.8×	179 1.4×	122 1.3×	111 1.6×	19	877
T Arai United States	8	221 0.7×	273 0.9×	102 0.8×	58 0.6×	55 0.8×	13	502
Marica Arvigo Italy	22	244 0.8×	695 2.3×	70 0.5×	64 0.7×	244 3.6×	48	1.2k
Jeffrey S. Huo United States	18	392 1.3×	163 0.5×	81 0.6×	69 0.7×	36 0.5×	32	761
Emilia Ballarè Italy	13	347 1.1×	368 1.2×	58 0.4×	213 2.3×	114 1.7×	14	757
Ron G. Rosenfeld United States	18	538 1.7×	828 2.8×	207 1.6×	217 2.3×	101 1.5×	21	1.2k
Jean-François Vanbellinghen Belgium	10	149 0.5×	110 0.4×	42 0.3×	74 0.8×	100 1.5×	18	542
Shirley M. Myers Canada	13	380 1.2×	268 0.9×	92 0.7×	188 2.0×	138 2.0×	26	820
Tineke Stelwagen Netherlands	4	397 1.3×	465 1.6×	116 0.9×	217 2.3×	262 3.9×	7	999
Dieter Engelhardt Germany	13	217 0.7×	289 1.0×	316 2.4×	58 0.6×	233 3.4×	19	631

Countries citing papers authored by J Zapf

Since Specialization

Citations

This map shows the geographic impact of J Zapf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Zapf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Zapf more than expected).

Fields of papers citing papers by J Zapf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Zapf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Zapf. The network helps show where J Zapf may publish in the future.

Co-authorship network of co-authors of J Zapf

This figure shows the co-authorship network connecting the top 25 collaborators of J Zapf. A scholar is included among the top collaborators of J Zapf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Zapf. J Zapf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Zapf, J, et al.. (2000). [Spectrum of effectiveness of insulin-like growth factors (IGF)].. PubMed. 130(6). 190–5. 2 indexed citations

Schmitt, Sarah, et al.. (1997). High molecular weight forms of IGF-II ('big-IGF-II') released by Wilms' tumor cells. European Journal of Endocrinology. 137(4). 396–401. 10 indexed citations

Møller, Niels, Jan Frystyk, Casper Skjærbæk, et al.. (1996). Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors.. PubMed. 39(12). 1534–5. 6 indexed citations

Schmid, Christoph, I. Schläpfer, Annika Keller, et al.. (1995). Effects of Insulin-like Growth Factor (IGF) Binding Proteins (BPs)-3 and -6 on DNA Synthesis of Rat Osteoblasts: Further Evidence for a Role of Auto-/Paracrine IGF I but Not IGF II in Stimulating Osteoblast Growth. Biochemical and Biophysical Research Communications. 212(1). 242–248. 28 indexed citations

Schofield, Paul N., et al.. (1995). Expression of a high molecular weight form of insulin-like growth factor II in a Beckwith-Wiedemann syndrome associated adrenocortical adenoma. Cancer Letters. 94(1). 71–77. 6 indexed citations

Caroni, Pico, et al.. (1994). Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4.. The Journal of Cell Biology. 125(4). 893–902. 89 indexed citations

Zapf, J. (1994). Non‐islet‐cell tumour hypoglycaemia. Clinical Endocrinology. 41(3). 402–402. 2 indexed citations

Andress, D.L., et al.. (1993). Carboxy-Truncated Insulin-like Growth Factor-Binding Protein-5 Stimulates Mitogenesis in Osteoblast-like Cells. Biochemical and Biophysical Research Communications. 195(1). 25–30. 110 indexed citations

Scholz, Holger C., W. Baier, Peter J. Ratcliffe, et al.. (1992). Insulin-like growth factors decrease oxygen-regulated erythropoietin production by human hepatoma cells (Hep G2). American Journal of Physiology-Cell Physiology. 263(2). C474–C479. 64 indexed citations

10.

Kossodo, S de, Georges E. Grau, Pascal Pointaire, et al.. (1992). Tumor necrosis factor alpha is involved in mouse growth and lymphoid tissue development.. The Journal of Experimental Medicine. 176(5). 1259–1264. 55 indexed citations

11.

Tamura, Kouichi, Masakazu Kobayashi, Yoshinori Ishii, et al.. (1989). Primary Structure of Rat Insulin-like Growth Factor-I and Its Biological Activities. Journal of Biological Chemistry. 264(10). 5616–5621. 15 indexed citations

12.

Connor, Helen E., et al.. (1989). Tumour hypoglycaemia: raised tumour IGFII mRNA associated with reduced plasma somatomedins. British Journal of Cancer. 60(5). 661–663. 10 indexed citations

13.

Haselbacher, Gisela K., J.C. Irminger, J Zapf, Walter Ziegler, & R Humbel. (1987). Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level.. Proceedings of the National Academy of Sciences. 84(4). 1104–1106. 170 indexed citations

14.

Zapf, J & E. R. Froesch. (1986). Pathophysiological and Clinical Aspects of the Insulin-Like Growth Factors. Hormone Research. 24(2-3). 160–165. 34 indexed citations

15.

Peter, H J, et al.. (1976). [Malignant hyperthermia: attempt at an early diagnosis by means of determination of creatine phosphokinase (CPK) and its isoenzymes].. PubMed. 106(29). 987–91. 1 indexed citations

16.

Zapf, J, Michael Mäder, M. Waldvogel, & Froesch Er. (1975). Nonsuppressible insulin-like activity: biological activity and receptor binding.. PubMed. 11(7). 664–78. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact